Figure 3.
Figure 3. SU5416 levels at 145 mg/m2 repeat schedule: comparison of patients with AML or solid tumors. SU5416 at a dose of 145 mg/m2 upon chronic dosing; mean plasma concentration versus time profile comparing patients with acute myeloid leukemia versus patients with miscellaneous solid tumors.

SU5416 levels at 145 mg/m2 repeat schedule: comparison of patients with AML or solid tumors. SU5416 at a dose of 145 mg/m2 upon chronic dosing; mean plasma concentration versus time profile comparing patients with acute myeloid leukemia versus patients with miscellaneous solid tumors.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal